Embargoed until 11:45 a.m. CT/12:45 p.m. ET Sunday, Nov. 17, 2019
PHILADELPHIA, Nov. 17, 2019 — The American Heart Association, a global force for longer, healthier lives, has awarded its Population Research Prize to Margaret M. Redfield, M.D., director of the Mayo Circulatory Failure Division, Department of Cardiovascular Diseases and co-director of the Mayo Cardiorenal Research Laboratory at the Mayo Clinic in Rochester, Minnesota.
“Dr. Redfield’s seminal work with the population of Olmsted County, Minnesota, has greatly deepened our understanding of heart failure with preserved ejection fraction, or HFpEF, which can be a very challenging diagnosis,” said American Heart Association President Robert A. Harrington, M.D., FAHA, who presented the award.
The award was presented today at the American Heart Association’s Scientific Sessions 2019 in Philadelphia. The Association’s Scientific Sessions is an annual, premier global exchange of the latest advances in cardiovascular science for researchers and clinicians.
“Dr. Redfield’s epidemiologic work with cohorts in Minnesota allowed her to determine the incidence, prevalence, risk factors and demographics of patients affected by a condition that accounts for half of all those admitted to clinics and hospitals for heart failure,” Dr. Harrington said. “While continuing to do her own research in this important field, she has also helped to train the next generation of cardiovascular investigators. Many of her postdoctoral trainees have gone on to become highly respected cardiologists and independent researchers in cardiovascular science.”
Dr. Redfield earned her medical degree from Tulane University School of Medicine. She has been the principal investigator, co-investigator or consultant on more than 100 federal, industry or foundation-funded grants; serves as author or co-author on hundreds of peer-reviewed articles, book chapters, editorials, abstracts and letters on questions related to heart failure and pulmonary hypertension.
- For more news at AHA Scientific Sessions 2019, follow us on Twitter @HeartNews #AHA19.
The American Heart Association’s Scientific Sessions is a premier global exchange of the latest advances in cardiovascular science for researchers and clinicians. Scientific Sessions 2019 is November 16-18 at the Pennsylvania Convention Center in Philadelphia. More than 12,000 leading physicians, scientists, cardiologists and allied health care professionals from around the world convene at the Scientific Sessions to participate in basic, clinical and population science presentations, discussions and curricula that can shape the future of cardiovascular science and medicine, including prevention and quality improvement. During the three-day meeting, attendees receive exclusive access to over 4,100 original research presentations and can earn Continuing Medical Education (CME), Continuing Education (CE) or Maintenance of Certification (MOC) credits for educational sessions. Engage in the Scientific Sessions conversation on social media via #AHA19.
About the American Heart Association
The American Heart Association is a relentless force for a world of longer, healthier lives. We are dedicated to ensuring equitable health in all communities. Through collaboration with numerous organizations, and powered by millions of volunteers, we fund innovative research, advocate for the public’s health and share lifesaving resources. The Dallas-based organization has been a leading source of health information for nearly a century. Connect with us on heart.org, Facebook, Twitter or by calling 1-800-AHA-USA1.
For Media Inquiries and AHA Volunteer Expert Perspective:
AHA News Media in Dallas: 214-706-1173
AHA News Media Office, Nov. 16-18, 2019 at the Pennsylvania Convention Center, Philadelphia: 215-418-2450
For Public Inquiries: 1-800-AHA-USA1 (242-8721)